This announcement is a separate document:
昆药集团关于收购昆明华润圣火药业51%股权的进展公告
KPC Group\'s progress announcement on the acquisition of 51% of Kunming Huarun Shenghuo Pharmaceutical
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.